Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Longo-Muñoz, Federico
266  Ergebnisse:
Personensuche X
?
1

Lurbinectedin in patients with pretreated neuroendocrine tu..:

Longo-Muñoz, Federico ; Castellano, Daniel ; Alexandre, Jerome...
European Journal of Cancer.  172 (2022)  - p. 340-348 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Association of the Lung Immune Prognostic Index with Immuno..:

Auclin, Edouard ; Vuagnat, Perrine ; Smolenschi, Cristina...
Cancers.  13 (2021)  15 - p. 3776 , 2021
Link: https://doi.org/10.3390/..
 
?
3

Early Clinical Experience with Trifluridine/Tipiracil for R..:

García-Alfonso, Pilar ; Muñoz, Andrés ; Jiménez-Castro, Jerónimo...
Cancers.  13 (2021)  18 - p. 4514 , 2021
Link: https://doi.org/10.3390/..
 
?
4

The subgroups of the phase III RECOURSE trial of trifluridi..:

Van Cutsem, Eric ; Mayer, Robert J. ; Laurent, Stéphanie...
European Journal of Cancer.  90 (2018)  - p. 63-72 , 2018
Link: https://doi.org/10.1016/..
 
?
5

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorecta..:

Carrato, Alfredo ; Abad, Albert ; Massuti, Bartomeu...
European Journal of Cancer.  81 (2017)  - p. 191-202 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Efficacy and safety of trifluridine/tipiracil in older and ..:

Shitara, Kohei ; Doi, Toshihiko ; Hosaka, Hisashi...
Gastric Cancer;25.  , 2022
Link: https://hdl.handle.net/1..
 
?
7

Lurbinectedin in patients with pretreated neuroendocrine tu..:

Longo-Muñoz, Federico ; Castellano, D ; Alexandre, Jerome...
European Journal of Cancer;172.  , 2022
Link: https://hdl.handle.net/1..
 
?
8

Initial single-center experience of PIPAC in patients with ..:

Cuadrado Ayuso, Marta ; Cabañas Montero, Jacobo ; Priego Jiménez, Pablo...
Cirugía Española (English Edition).  99 (2021)  5 - p. 354-360 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Early Clinical Experience with Trifluridine/Tipiracil for R..:

Muñoz, Andrés ; Jiménez-Castro, Jerónimo ; Jimenez-Fonseca, Paula...
Cancers;13(18).  , 2021
Link: https://hdl.handle.net/1..
 
?
10

Early Clinical Experience with Trifluridine/Tipiracil for R..:

García-Alfonso, Pilar ; Muñoz, Andrés ; Jiménez-Castro, Jerónimo...
https://www.mdpi.com/2072-6694/13/18/4514/htm.  , 2021
Link: http://hdl.handle.net/10..
 
?
11

Early Clinical Experience with Trifluridine/Tipiracil for R..:

García-Alfonso, Pilar ; Muñoz, Andrés ; Jiménez-Castro, Jerónimo...
https://www.mdpi.com/2072-6694/13/18/4514/htm.  , 2021
Link: http://hdl.handle.net/10..
 
?
12

Early Clinical Experience with Trifluridine/Tipiracil for R..:

García-Alfonso, Pilar ; Muñoz, Andrés ; Jiménez-Castro, Jerónimo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468101/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Effect of lurbinectedin on the QTc interval in patients wit..:

Fudio, Salvador ; Tabernero Caturla, Josep ; Chawla, Sant P...
Cancer Chemotherapy and Pharmacology;87.  , 2020
Link: https://hdl.handle.net/1..
 
?
14

The subgroups of the phase III RECOURSE trial of trifluridi..:

Van Cutsem, Eric ; Mayer, Robert J ; Laurent, Stéphanie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493695/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
15

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorecta..:

Carrato, Alfredo ; Abad, Albert ; Massuti, Bartomeu...
http://www.sciencedirect.com/science/article/pii/S0959804917309516?via%3Dihub.  , 2017
Link: https://hdl.handle.net/2..
 
1-15